Stanley Cohen Archives
Feb. 6, 2020—Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97.
Oct. 13, 2017—A new exhibit on display at the Wond'ry honors the discoveries of Vanderbilt's Nobel laureates by translating them into beautiful works of art.
Feb. 28, 2017—The Vanderbilt University School of Medicine is now soliciting applications for research awards from the Stanley Cohen Innovation Fund.
Aug. 25, 2016—When Tom Daniel, M.D., joined the Vanderbilt University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF).
Jun. 6, 2013—Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom.